Nature’s Sunshine Products, Inc. has announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock, to be sold by Fosun Pharma USA, Inc. The proceeds ...
Fosun Pharma USA is selling up to 2,854,607 shares of common stock held in Nature’s Sunshine Products (NASDAQ:NATR) at a price of $12.00 per share. The offering is expected to close on June 27, 2025, ...
Nature’s Sunshine delivered strong Q3 2025 results, driven by robust growth in Asia and recurring autoship sales. NATR's international focus, especially in Asia and Europe, positions it for continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results